- $3.49bn
- $4.00bn
- $970.00m
- 78
- 11
- 90
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 418 | 495 | 536 | 855 | 970 |
Cost of Revenue | |||||
Gross Profit | 379 | 451 | 480 | 738 | 839 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 400 | 499 | 672 | 1,156 | 1,135 |
Operating Profit | 17.5 | -3.91 | -136 | -301 | -165 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.06 | -27.6 | -178 | -314 | -169 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.1 | -24.4 | -180 | -318 | -179 |
Net Income Before Extraordinary Items | |||||
Net Income | 27.1 | -24.4 | -180 | -318 | -179 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 27.1 | -24.4 | -180 | -318 | -179 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.589 | -0.349 | -2.67 | -4.13 | -2.5 |